1. Home
  2. BOLT vs NCRA Comparison

BOLT vs NCRA Comparison

Compare BOLT & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • NCRA
  • Stock Information
  • Founded
  • BOLT 2015
  • NCRA 2002
  • Country
  • BOLT United States
  • NCRA Taiwan
  • Employees
  • BOLT N/A
  • NCRA N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • NCRA Farming/Seeds/Milling
  • Sector
  • BOLT Health Care
  • NCRA Consumer Staples
  • Exchange
  • BOLT Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • BOLT 16.8M
  • NCRA 13.9M
  • IPO Year
  • BOLT 2021
  • NCRA N/A
  • Fundamental
  • Price
  • BOLT $0.35
  • NCRA $1.00
  • Analyst Decision
  • BOLT Hold
  • NCRA
  • Analyst Count
  • BOLT 5
  • NCRA 0
  • Target Price
  • BOLT $1.00
  • NCRA N/A
  • AVG Volume (30 Days)
  • BOLT 103.8K
  • NCRA 83.1K
  • Earning Date
  • BOLT 05-12-2025
  • NCRA 05-06-2025
  • Dividend Yield
  • BOLT N/A
  • NCRA N/A
  • EPS Growth
  • BOLT N/A
  • NCRA N/A
  • EPS
  • BOLT N/A
  • NCRA N/A
  • Revenue
  • BOLT $3,638,000.00
  • NCRA $17,013,132.00
  • Revenue This Year
  • BOLT N/A
  • NCRA N/A
  • Revenue Next Year
  • BOLT $77.48
  • NCRA N/A
  • P/E Ratio
  • BOLT N/A
  • NCRA N/A
  • Revenue Growth
  • BOLT N/A
  • NCRA N/A
  • 52 Week Low
  • BOLT $0.30
  • NCRA $0.70
  • 52 Week High
  • BOLT $1.34
  • NCRA $2.09
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 45.53
  • NCRA 53.09
  • Support Level
  • BOLT $0.35
  • NCRA $0.87
  • Resistance Level
  • BOLT $0.38
  • NCRA $1.03
  • Average True Range (ATR)
  • BOLT 0.03
  • NCRA 0.12
  • MACD
  • BOLT 0.00
  • NCRA 0.00
  • Stochastic Oscillator
  • BOLT 29.16
  • NCRA 52.38

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: